Pharmacokinetics of Thymoglobulin in Paediatric Haematopoietic Stem-cell Transplants
Pharmacokinetics and Pharmacodynamics of Thymoglobulin in Paediatric Haematopoietic Stem-cell Transplant Recipients
Sponsor: The Hospital for Sick Children
Terminated
The study was closed before 2017 due to inconclusive results from Lab
Other terminated trials from The Hospital for Sick Children
Other Genetic Disorder trials with similar outcome
A PHASE2 clinical study on Genetic Disorder and Malignancy, this trial is terminated or withdrawn. The trial is conducted by The Hospital for Sick Children and has accumulated 8 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jan 2023 — Jul 2024 [monthly]
Terminated PHASE2
-
Dec 2022 — Jan 2023 [monthly]
Terminated PHASE2
-
Jan 2021 — Dec 2022 [monthly]
Terminated PHASE2
▶ Show 3 earlier versions
-
Dec 2019 — Jan 2021 [monthly]
Terminated PHASE2
Status: Completed → Terminated
-
Jun 2018 — Dec 2019 [monthly]
Completed PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE2
First recorded
Nov 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- The Hospital for Sick Children
For direct contact, visit the study record on ClinicalTrials.gov .